And JAK inhibitors provide the most targeted approach to treating psoriatic arthritis yet. The types of psoriatic arthritis treatment options include:
Nonsteroidal anti-inflammatory drugs (NSAIDs) to help alleviate joint pain and swellingDMARDs — such as methotrexate, a common first-line treatment — to slow disease progressionBiologics, such as tumor necrosis factor (TNF) inhibitors or interleukin (IL)-17 inhibitors, to target and block specific inflammatory response pathways in the bodyJAK inhibitors, which are the most targeted disease-modifying therapyImmunosuppressants to lessen an overactive immune responseSteroids to reduce inflammation and ease symptoms, especially during a flareEnzyme inhibitors to slow down the inflammatory response
Because advanced psoriatic arthritis is more likely to cause joint damage, it’s important to get the condition under control. In many cases, if you haven’t responded to other disease-modifying psoriatic arthritis drugs, a JAK inhibitor may be worth a try. You’ve learned a lot about JAK inhibitors for psoriatic arthritis. So what’s next? Take some time to absorb all of this info and decide if JAK inhibitors are something you might want to consider.